Use of BODIPY-labelled ATP analogues in the development and validation of a fluorescence polarization-based assay for screening of kinase inhibitors

Files in this item
Date
2020Author
Moreira, Bernardo Pereira
Armstrong, Tom
Batista, Izabella Cristina Andrade
Tavares, Naiara Clemente
Pire, Camilla Valente
Falcone, Franco Harald
Dekken, Lodewijk
Quotable link
http://dx.doi.org/10.22029/jlupub-6471Original publication in
ACS omega 5 (2020), 9064-9070
Comment
This ACS article is provided to You under the terms of this ACS AuthorChoice/Editors’ Choice via Creative Commons CC-BY agreement between You and the American Chemical Society (“ACS”) https://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html